Open access
1,497
Views
1
CrossRef citations to date
0
Altmetric
Original Research
Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study
Jamie P. Dwyera Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, USAView further author information
, Abiy Agirob US Evidence, US Medical Affairs, AstraZeneca, Wilmington, DE, USACorrespondence[email protected]
View further author information
, View further author information
Pooja Desaic US Renal, US Medical Affairs, AstraZeneca, Wilmington, DE, USAView further author information
& Henry Cremisic US Renal, US Medical Affairs, AstraZeneca, Wilmington, DE, USAView further author information
Pages 1057-1066
|
Received 06 Jun 2023, Accepted 12 Jul 2023, Published online: 04 Aug 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.